Minimally Invasive Ablation Procedures for Morton and Other Peripheral Neuromas
Customize your policy alerts
Sign up for blue_shield_of_california Policy 7.01.147 alerts
Get alerted when Policy 7.01.147 changes without checking for updates manually.
Monitor payer policy activity
This policy governs intralesional alcohol injection, radiofrequency ablation, and cryoablation used to treat Morton neuroma and other peripheral neuromas. These procedures are considered investigational because evidence is insufficient to establish improved net health outcomes.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.